GLP-1 Weight Management
Tirzepatide is a dual GLP-1 and GIP receptor agonist that activates two incretin pathways simultaneously. For eligible patients, this may support appetite regulation, insulin sensitivity, and weight-management goals. Rani Beauty Clinic provides physician-supervised tirzepatide therapy with individualized dosing and metabolic monitoring.
Dual GLP-1 and GIP receptor activation for eligible weight-management plans
Published studies report meaningful average weight loss, with individual outcomes varying
Improves insulin sensitivity and metabolic markers beyond weight reduction
Weekly injection with structured dose escalation for optimal tolerability
Adults with obesity seeking the most effective available medical weight loss therapy
Those who have not achieved sufficient results with GLP-1-only medications
Individuals with insulin resistance or metabolic syndrome alongside obesity
Patients wanting a physician-managed, advanced approach to weight management
Tirzepatide activates both GLP-1 and GIP receptors, while semaglutide activates only GLP-1. This dual mechanism may produce greater weight loss and metabolic benefits. Clinical trials show tirzepatide achieves higher average weight loss compared to semaglutide.
Gastrointestinal side effects including nausea, diarrhea, and decreased appetite are most common, especially during dose escalation. These are generally mild to moderate and improve as your body adjusts. Our careful titration schedule helps minimize discomfort.
Tirzepatide eligibility depends on diagnosis, medical history, contraindications, and the specific medication formulation being considered. Our physician evaluates your complete health history to determine whether it is appropriate for you.
Book Your Visit at Rani Beauty Clinic and discover how tirzepatide weight loss can support your wellness journey.